Key Highlights
- Kathy Wilkinson appointed as Chief People Officer at Rapport Therapeutics.
- Brings over 20 years of HR experience from 2seventy bio and bluebird bio.
- Aims to enhance company culture and talent as Rapport expands its clinical-stage biotech programs.
Source: Business Wire
Notable Quotes
- “Bringing Kathy on board as our Chief People Officer is tremendously exciting as the Rapport team rapidly expands,” – Abraham Ceesay, Chief Executive Officer at Rapport Therapeutics, Inc
- “As the Rapport team executes its transformative vision for precision neuromedicine, we are building a culture that nurtures its core values and values our people while attracting and investing in diverse talent and ideas,” – Kathy Wilkinson, Chief People Officer at Rapport Therapeutics Inc
SoHC's Take
Rapport Therapeutics’ latest move to appoint Kathy Wilkinson as Chief People Officer underscores the company’s commitment to nurturing a vibrant culture and attracting top talent essential for advancing its precision neuromedicine programs. Wilkinson’s extensive background in human resources and her proven track record in fostering people-focused cultures at leading biotech companies positions her as the ideal leader to guide Rapport through its next growth phase. Her focus on building a team that aligns with the company’s core values and mission promises to further Rapport’s vision of transforming patient care in the neurological and psychiatric fields. With Wilkinson at the helm of people management, Rapport Therapeutics is poised to make significant strides in developing new classes of precision neuromedicines that offer better alternatives for patients, highlighting the crucial role of leadership and culture in driving innovation in the biotech industry.
